FHI vs HLNE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

FHI

39.5
AI Score
VS
FHI Wins

HLNE

37.5
AI Score

Investment Advisor Scores

FHI

40score
Recommendation
SELL

HLNE

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric FHI HLNE Winner
Revenue 479.76M 1.49B FHI
Net Income 157.95M 312.58M FHI
Net Margin 32.9% 21.0% HLNE
ROE 15.8% 24.2% FHI
ROA 5.8% 12.7% FHI
Total Assets 2.74B 2.47B HLNE
Debt/Equity 0.27 0.27 FHI
Free Cash Flow 98.15M 223.93M FHI

Relative Price Performance (Last 90 Days)

FHI 1M: +14.4% · 3M: +1.3% HLNE 1M: +4.4% · 3M: -10.9%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

HLNE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.9 · Price: $89.46

Fundamentals Snapshot

Metric FHI HLNE
Market Cap — —
Forward P/E 10.7 14.9
Trailing P/E 11.9 13.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.7% 0.6%
Operating Margin 0.3% 0.4%
EPS 5.39 6.74
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.